Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Community-dwelling Older Adults in Primary Care: A Randomized Controlled Trial
Experimental group
Atrophy+8
+ Behavior
+ Motor Activity
Screening Study
Summary
Study start date: August 8, 2023
Actual date on which the first participant was enrolled.This study focuses on helping older adults who live in the community and may be at risk of a condition called sarcopenia, which involves the loss of muscle mass and strength. Researchers aim to see if a 12-week program that combines exercise and nutrition can improve muscle health and overall well-being compared to those who receive the usual care. This is important because improving muscle health can help older adults maintain their independence and quality of life. Participants in the study will be divided into two groups. One group will follow a specific exercise and nutrition program, while the other group will continue with their usual care. Throughout the 12-week period, researchers will assess changes in muscle health, recovery of physical function, and how satisfied participants are with the program. The study does not mention any specific risks, but the potential benefit is that participants could see improvements in their muscle strength and overall health.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.94 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Screening Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 65 to 85 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * 65 to 85 years of age * Men and women with possible sarcopenia * If included in the possible sarcopenia criteria in the 2019 Asian Working Group for Sarcopenia(AWGS) criteria A Simple Questionnaire to Rapidly Diagnose Sarcopenia(The Korean SARC-F questionnaire) score is 4 or higher; or Calf circumference (Men's: \<34 cm, Women's: \<33 cm) + Decreased muscle strength (male: \<28kg, female: \<18kg) or Decreased physical function (if it takes more than 12 seconds from the 5-chair stand test) * \[(1) and {(2) or (3)}\] Exclusion Criteria: * Renal failure: Serum creatine exceeding 2.0 mg/dl * Uncontrolled hypertension: systolic/diastolic blood pressure greater than 150/90 millimeter of mercury(mmHg) * Uncontrolled diabetes: glycated hemoglobin (HbA1C) over 7.5% * Subject who are receiving treatment (steroids, anticancer drugs, etc.) that can affect muscle mass * Subjects with myocardial infarction or angina pectoris, stroke disease * Malignant tumor: Subject who has a history of cancer within 5 years or is currently receiving treatment * Subjects who have liver cirrhosis and uncontrolled hepatitis (Aspartate aminotransferase or Alanine aminotransferase is more than three times the upper limit of the reference range) * Subjects who have chronic diseases such as musculoskeletal disorders that are impossible to exercise * Subjects who are allergic to soybeans, coix, and brown rice
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
Dongdong Family Medicine Clinic
Dobong, South KoreaOpen Dongdong Family Medicine Clinic in Google MapsDongbu-hanil Surgery Clinic
Dobong, South KoreaSeoulbom United Clinic
Dobong, South Korea